Patents by Inventor Corcept Therapeutics, Inc.

Corcept Therapeutics, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHENYL HETEROCYCLOALKYL GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20130225633
    Abstract: The present invention provides phenyl-heterocycloalkyl fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: February 26, 2013
    Publication date: August 29, 2013
    Applicant: Corcept Therapeutics, Inc.
    Inventor: Corcept Therapeutics, Inc.
  • OPTIMIZING MIFEPRISTONE ABSORPTION
    Publication number: 20130131030
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: November 15, 2012
    Publication date: May 23, 2013
    Applicant: CORCEPT THERAPEUTICS, INC.
    Inventor: Corcept Therapeutics, Inc.